科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/03/29 | 1,715 | 1,728 | 1,695 | 1,724 | +17 | +1% | 371,000 |
| 2013/03/28 | 1,716 | 1,716 | 1,685 | 1,707 | +1 | +0.1% | 360,000 |
| 2013/03/27 | 1,699 | 1,706 | 1,683 | 1,706 | +11 | +0.6% | 386,000 |
| 2013/03/26 | 1,693 | 1,699 | 1,684 | 1,695 | +6 | +0.4% | 412,000 |
| 2013/03/25 | 1,675 | 1,695 | 1,668 | 1,689 | +34 | +2.1% | 434,000 |
| 2013/03/22 | 1,676 | 1,693 | 1,652 | 1,655 | -21 | -1.3% | 558,000 |
| 2013/03/21 | 1,671 | 1,676 | 1,603 | 1,676 | -14 | -0.8% | 1,378,000 |
| 2013/03/19 | 1,685 | 1,705 | 1,681 | 1,690 | +6 | +0.4% | 548,000 |
| 2013/03/18 | 1,712 | 1,712 | 1,665 | 1,684 | -37 | -2.1% | 747,000 |
| 2013/03/15 | 1,715 | 1,743 | 1,714 | 1,721 | +13 | +0.8% | 1,470,000 |
| 2013/03/14 | 1,712 | 1,720 | 1,679 | 1,708 | -13 | -0.8% | 757,000 |
| 2013/03/13 | 1,728 | 1,729 | 1,690 | 1,721 | -3 | -0.2% | 713,000 |
| 2013/03/12 | 1,720 | 1,740 | 1,716 | 1,724 | +7 | +0.4% | 441,000 |
| 2013/03/11 | 1,720 | 1,724 | 1,710 | 1,717 | -3 | -0.2% | 295,000 |
| 2013/03/08 | 1,720 | 1,732 | 1,709 | 1,720 | -3 | -0.2% | 577,000 |
| 2013/03/07 | 1,713 | 1,732 | 1,700 | 1,723 | -5 | -0.3% | 542,000 |
| 2013/03/06 | 1,711 | 1,741 | 1,696 | 1,728 | +1 | +0.1% | 575,000 |
| 2013/03/05 | 1,715 | 1,774 | 1,704 | 1,727 | +52 | +3.1% | 825,000 |
| 2013/03/04 | 1,627 | 1,690 | 1,627 | 1,675 | +44 | +2.7% | 905,000 |
| 2013/03/01 | 1,605 | 1,642 | 1,585 | 1,631 | +18 | +1.1% | 521,000 |
| 2013/02/28 | 1,605 | 1,625 | 1,578 | 1,613 | +10 | +0.6% | 638,000 |
| 2013/02/27 | 1,625 | 1,636 | 1,598 | 1,603 | -30 | -1.8% | 523,000 |
| 2013/02/26 | 1,631 | 1,642 | 1,615 | 1,633 | +4 | +0.2% | 411,000 |
| 2013/02/25 | 1,560 | 1,640 | 1,560 | 1,629 | +75 | +4.8% | 787,000 |
| 2013/02/22 | 1,530 | 1,557 | 1,521 | 1,554 | +18 | +1.2% | 608,000 |
| 2013/02/21 | 1,535 | 1,555 | 1,535 | 1,536 | -9 | -0.6% | 336,000 |
| 2013/02/20 | 1,545 | 1,550 | 1,525 | 1,545 | +6 | +0.4% | 358,000 |
| 2013/02/19 | 1,504 | 1,549 | 1,501 | 1,539 | +45 | +3% | 433,000 |
| 2013/02/18 | 1,469 | 1,503 | 1,468 | 1,494 | +17 | +1.2% | 265,000 |
| 2013/02/15 | 1,469 | 1,482 | 1,460 | 1,477 | +12 | +0.8% | 493,000 |
| 2013/02/14 | 1,469 | 1,481 | 1,464 | 1,465 | -11 | -0.7% | 291,000 |
| 2013/02/13 | 1,475 | 1,497 | 1,466 | 1,476 | +2 | +0.1% | 269,000 |
| 2013/02/12 | 1,466 | 1,485 | 1,466 | 1,474 | +10 | +0.7% | 290,000 |
| 2013/02/08 | 1,450 | 1,478 | 1,438 | 1,464 | +15 | +1% | 347,000 |
| 2013/02/07 | 1,475 | 1,487 | 1,431 | 1,449 | -27 | -1.8% | 540,000 |
| 2013/02/06 | 1,532 | 1,532 | 1,466 | 1,476 | -53 | -3.5% | 555,000 |
| 2013/02/05 | 1,507 | 1,539 | 1,500 | 1,529 | +34 | +2.3% | 425,000 |
| 2013/02/04 | 1,503 | 1,511 | 1,487 | 1,495 | -7 | -0.5% | 220,000 |
| 2013/02/01 | 1,500 | 1,506 | 1,488 | 1,502 | +1 | +0.1% | 250,000 |
| 2013/01/31 | 1,482 | 1,506 | 1,466 | 1,501 | +24 | +1.6% | 336,000 |
| 2013/01/30 | 1,476 | 1,483 | 1,460 | 1,477 | +19 | +1.3% | 350,000 |
| 2013/01/29 | 1,430 | 1,470 | 1,429 | 1,458 | +28 | +2% | 369,000 |
| 2013/01/28 | 1,431 | 1,444 | 1,427 | 1,430 | -2 | -0.1% | 278,000 |
| 2013/01/25 | 1,395 | 1,436 | 1,395 | 1,432 | +37 | +2.7% | 278,000 |
| 2013/01/24 | 1,367 | 1,395 | 1,366 | 1,395 | +28 | +2% | 174,000 |
| 2013/01/23 | 1,359 | 1,375 | 1,358 | 1,367 | -1 | -0.1% | 181,000 |
| 2013/01/22 | 1,364 | 1,386 | 1,357 | 1,368 | -1 | -0.1% | 234,000 |
| 2013/01/21 | 1,371 | 1,379 | 1,366 | 1,369 | -2 | -0.1% | 166,000 |
| 2013/01/18 | 1,353 | 1,376 | 1,353 | 1,371 | +9 | +0.7% | 492,000 |
| 2013/01/17 | 1,353 | 1,371 | 1,353 | 1,362 | -14 | -1% | 388,000 |
2951～
3000
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 403,600円 | +30.5% | +111.0% | 4.71% | 11.38倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 361,500円 | +7.9% | +8.9% | 3.43% | 7.73倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 193,300円 | +5.0% | +1.5% | 0.00% | 16.59倍 | 4.41倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 379,000円 | +14.5% | -2.3% | 2.37% | 13.87倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 189,500円 | - | - | 0.00% | - | 87.77倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
